Riskpilot← Back to searchSign inGet full accessVISUS ØYELEGESENTER AS
ASActiveOrg 924925116Olav Tryggvasons Gate 24B, 7011 TrondheimMedical specialists activities · NACE 8622Est. 20203 employees
Revenue 2024
NOK 10,7M
-9% vs 2023
EBITDA margin
32.1%
-42% vs 2023
Equity ratio
20.1%
Financial strength
Net profit 2024
NOK 2,1M
-47% vs 2023
| Revenue | NOK 10,7M | -9% |
| EBITDA | NOK 3,4M | -42% |
| Net profit | NOK 2,1M | -47% |
| Total assets | NOK 5,1M | -12% |
| Equity | NOK 1M | +294% |
| Employees | 3 | — |
Legal name
VISUS ØYELEGESENTER AS
Org number
924925116
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
15. april 2020
Share capital
NOK 37 500
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Spesialisert legevirksomhet.
Address
Olav Tryggvasons Gate 24B, 7011 Trondheim
Phone
+4773807400
Email
post@visusoyelegesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 047 | 10 215 | 11 095 | 11 703 | 10 664 |
| Staff expenses | −1 145 | −2 493 | −2 547 | −2 789 | −2 910 |
| EBITDA | 926 | 4 387 | 5 764 | 5 879 | 3 420 |
| Depreciation & amort. | −504 | −868 | −881 | −886 | −725 |
| EBIT | 422 | 3 520 | 4 883 | 4 992 | 2 696 |
| Net financials | 30 | −6 | −3 | 50 | 33 |
| Profit before tax | 391 | 3 514 | 4 880 | 5 042 | 2 728 |
| Tax | 85 | 773 | 1 134 | 1 049 | 600 |
| Net profit | 307 | 2 741 | 3 746 | 3 993 | 2 128 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 051 | 4 148 | 5 531 | 5 844 | 5 119 |
| Equity | 31 | 72 | 118 | 261 | 1 027 |
| Long-term debt | 5 246 | 42 | 0 | 0 | 0 |
| Short-term debt | 774 | 4 033 | 5 413 | 5 584 | 4 092 |
| Total debt | 6 020 | 4 076 | 5 413 | 5 584 | 4 092 |
EBITDA margin
32.1%
This company
15.8%
Market median
+103% vs market
20202024
Equity ratio
20.1%
This company
38.2%
Market median
-47% vs market
20202024
Return on equity
207.2%
This company
18.4%
Market median
+1026% vs market
20202024
Net profit margin
20.0%
This company
8.1%
Market median
+147% vs market
20202024
Asset turnover
2.08×
This company
1.12×
Market median
+86% vs market
20202024
Debt / equity
3.98×
This company
0.62×
Market median
-542% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 | |
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Øyelege Arnt-Ole Tvenning As
VISUS ØYELEGESENTER AS Board members of VISUS ØYELEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Andreas Dall Frøseth | Board of Directors | 0 companies |
| Arnt-Ole Tvenning | Board of Directors | 0 companies |
| Sammy Basit | Chairman | 0 companies |